Prospective RBC phenotype matching ina stroke-Prevention trial in sickle cell anemia: A multicenter transfusion trial

Transfusion

Volumn 41, Issue 9, 2001, Pages 1086-1092

  Vichinsky, Elliott P ^a,b,c,d,e,f   Luban, Naomi L C ^a,b,c,d,e,f   Wright, Elizabeth ^a,b,c,d,e,f   Olivieri, Nancy ^a,b,c,d,e,f   Driscoll, Catherine ^a,b,c,d,e,f   Pegelow, Charles H ^a,b,c,d,e,f   Adams, Robert J ^a,b,c,d,e,f  

^a CHILDREN S HOSPITAL OAKLAND   (United States)

^b CHILDREN'S NATIONAL MEDICAL CENTER   (United States)

^c NEW ENGLAND RESEARCH INSTITUTES   (United States)

^d HOSPITAL FOR SICK CHILDREN   (Canada)

^e UNIVERSITY OF MIAMI   (United States)

^f MEDICAL COLLEGE OF GEORGIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADOLESCENT; ALLOIMMUNIZATION; ANTIBODY PRODUCTION; ANTIBODY SCREENING; ARTICLE; BLOOD TRANSFUSION; BLOOD TRANSFUSION REACTION; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; ERYTHROCYTE TRANSFUSION; FEMALE; HEMOLYSIS; HUMAN; MAJOR CLINICAL STUDY; MALE; MULTICENTER STUDY; PHENOTYPE; PRIMARY PREVENTION; PROSPECTIVE STUDY; RANDOMIZED CONTROLLED TRIAL; SCHOOL CHILD; SICKLE CELL ANEMIA; STROKE;

ADOLESCENT; ANEMIA, SICKLE CELL; AUTOANTIBODIES; BLOOD GROUPING AND CROSSMATCHING; BLOOD TRANSFUSION; CEREBROVASCULAR ACCIDENT; CHILD; CHILD, PRESCHOOL; ERYTHROCYTES; FEMALE; HUMANS; ISOANTIBODIES; MALE; PHENOTYPE; PROSPECTIVE STUDIES;

EID: 0034858110     PISSN: 00411132     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1537-2995.2001.41091086.x     Document Type: Article

References (42)

1. Comprehensive care in sickle cell disease: Its impact on morbidity and mortality
2. Transfusion therapy
3. Transfusion and alloimmunization in sickle cell disease
4. Causes and outcomes of the acute chest syndrome in sickle cell disease
5. Consensus document for transfusion-related iron overload
6. Current issues with blood transfusions in sickle cell disease
7. Indications for red cell transfusion in sickle cell disease
8. Effects of a long-term transfusion regimen on sickle cell-related illnesses
9. A comparison of conservative and aggressive transfusion regimens in the perioperative management of sickle cell disease
10. Prevention of a first stroke by transfusions in children with sickle cell anemia and abnormal results on transcranial Doppler ultrasonography
11. Experience with donors matched for minor blood group antigens in patients with sickle cell anemia who are receiving chronic transfusion therapy
12. Delayed hemolytic transfusion reaction due to anti-Js(a) in an alloimmunized patient with a sickle cell syndrome
13. Erythrocyte autoantibodies in paediatric patients with sickle cell disease receiving transfusion therapy: Frequency, characteristics and significance
14. Risk of alloimmunization and delayed hemolytic transfusion reactions in patients with sickle cell disease
15. Red cell alloimmunization in sickle cell disease
16. Delayed hemolytic transfusion reaction presenting as sickle-cell crisis
17. Delayed hemolytic transfusion reaction presenting as a painful crisis in a patient with sickle cell anemia
18. Delayed hemolytic transfusion reactions in sickle cell disease: Simultaneous destruction of recipients' red cells
19. Delayed hemolytic transfusion reactions (DHTR) in sickle cell disease (SCD): Evidence for autologous RBC destruction (abstract)
20. Post-transfusion alloimmunization in patients with sickle cell disease
21. The sickle cell hemolytic transfusion reaction syndrome
22. Association of sickle cell disease, priapism, exchange transfusion and neurological events: ASPEN syndrome
23. Severe autoimmune hemolytic anemia induced by transfusion in two alloimmunized patients with sickle cell disease (abstract)
24. Alloimmunization in sickle cell anemia and transfusion of racially unmatched blood
25. HLA-B35 is associated with red cell alloimmunization in sickle cell disease
26. Broadening the base of a rare donor program by targeting minority populations
27. Bed blood cell alloimmunization in sickle cell disease: The influence of racial and antigenic pattern differences between donors and recipients in Brazil
28. Association of HLA and autoantibody in transfused sickle cell disease patients
29. Antigen-matched donor blood in the transfusion management of patients with sickle cell disease
30. Transfusion therapy: Clinical principles and practice
31. Comparison of the polyethylene glycol antiglobulin test and the use of enzymes in antibody detection and identification
32. Rare blood for patients with anemia: Sickle cell disease
33. Effects of total hemoglobin and hemoglobin S concentration on cerebral blood flow during transfusion therapy to prevent stroke in sickle cell disease
34. Natural history of blood pressure in sickle cell disease: Risks for stroke and death associated with relative hypertension in sickle cell anemia
35. Neurologic events after partial exchange transfusion for priapism in sickle cell disease
36. Sickle cell chronic lung disease: Prior morbidity and the risk of pulmonary failure
37. Bone marrow transplantation versus periodic prophylactic blood transfusion in sickle cell patients at high risk of ischemic stroke: A decision analysis
38. Erythrocytapheresis for chronically transfused children with sickle cell disease: An effective method for maintaining a low hemoglobin S level and reducing iron overload
39. A simple, practical model for reducing alloimmunization in patients with sickle cell disease
40. Screening with monoclonal anti-Fy3 to provide blood for phenotype-matched transfusions for patients with sickle cell disease